Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Visual inspection cannot detect molecular degradation, and even clear, colorless solutions may have reduced therapeutic activity
Some patients prefer this consistency
Retatrutide has not been approved by the MHRA
Reviewed on Nov 21, 2025
review your medication's prescribing information with your licensed healthcare provider Key research context: A 2024 phase 2 RCT documented 2.6% hip and 2.1% lumbar spine BMD reduction in a specific semaglutide study population within 52 weeks
US$ 26.99
US$ 27.16
US$ 24.47
US$ 21.09
US$ 20.79
US$ 29.03
US$ 29.52
